Relmada Therapeutics Inc (RLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 10,327 | 10,221 | 18,218 | 19,076 | 23,009 |
| Operating Income | -10,327 | -10,221 | -18,218 | -19,076 | -23,009 |
| Other Income | 236 | 355 | 659 | 419 | 1,283 |
| Pre-tax Income | -10,092 | -9,866 | -17,560 | -18,657 | -21,726 |
| Net Income Continuous | -10,092 | -9,866 | -17,560 | -18,657 | -21,726 |
| Net Income | $-10,092 | $-9,866 | $-17,560 | $-18,657 | $-21,726 |
| EPS Basic Total Ops | -0.30 | -0.30 | -0.58 | -0.62 | -0.72 |
| EPS Basic Continuous Ops | -0.30 | -0.30 | -0.58 | -0.62 | -0.72 |
| EPS Diluted Total Ops | -0.30 | -0.30 | -0.58 | -0.62 | -0.72 |
| EPS Diluted Continuous Ops | -0.30 | -0.30 | -0.58 | -0.62 | -0.72 |
| EPS Diluted Before Non-Recurring Items | -0.30 | -0.30 | -0.58 | -0.62 | -0.72 |
| EBITDA(a) | $-10,327 | $-10,221 | $-18,218 | $-19,076 | $-23,009 |